Saudi Food and Drug Authority completes inspection at Concord Biotech’s manufacturing unit II

Concord Biotech Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 543960 | NSE: CONCORDBIO

17 May 2024 Evaluate

Saudi Food and Drug Authority has successfully completed inspection of Concord Biotech’s manufacturing unit II, (formulation facility), located at Valthera, Gujarat from May 14, 2024 to May 16, 2024.

In February 2024, Ministry of Health Pharmacy and Poisons Board, Republic of Kenya had completed inspection at Concord Biotech’s Unit II (formulation facility), located at Valthera-Dholka in Ahmedabad, Gujarat.

Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.

Peers

Company Name	CMP
Sun Pharma. Inds.	1842.00
Dr. Reddys Labs.	1161.00
Cipla	1365.00
Lupin	2096.00
Zydus Lifesciences	1119.50
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.